Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Alberto Berman"'
Autor:
Alberto Berman
Publikováno v:
Revista Argentina de Reumatología, Vol 25, Iss 2 (2014)
El estudio de las espondiloartritis en los últimos años ha despertado el interés, generando cada vez más preguntas y necesitando más respuestas. Clásicamente se agrupa bajo la denominación de espondiloartritis a un conjunto de enfermedades que
Externí odkaz:
https://doaj.org/article/609e01c8eb8d4c8c82a981ec30ccf2f6
Autor:
Patrick Durez, Pierre Vandepapeliere, Pedro Miranda, Antoaneta Toncheva, Alberto Berman, Tatjana Kehler, Eugenia Mociran, Bruno Fautrel, Xavier Mariette, Olivier Dhellin, Bernard Fanget, Stephane Ouary, Géraldine Grouard-Vogel, Marie-Christophe Boissier
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113465 (2014)
OBJECTIVES:Active immunization, or vaccination, with tumor necrosis factor (TNF)-Kinoid (TNF-K) is a novel approach to induce polyclonal anti-TNF antibodies in immune-mediated inflammatory diseases. This study was performed to transfer the proof of c
Externí odkaz:
https://doaj.org/article/f926eea74a0d438b8096e2e881798036
Autor:
Nicolino Ruperto, Daniel J. Lovell, Alberto Berman, Francisco Ávila-Zapata, Gerd Horneff, Maria Alessio, Mara L. Becker, Alexandre Belot, Ruben Burgos-Vargas, Maria L. Gamir, Claudia Goldenstein-Schainberg, Iloite M. Scheibel, Maria T. Terreri, Lawrence Zemel, Joe Zhuo, Margarita Askelson, Robert Wong, Alberto Martini, Hermine I. Brunner
Objective: To describe longitudinal changes in patient-reported outcomes (PROs) in children with polyarticular-course juvenile idiopathic arthritis (pJIA) treated with subcutaneous abatacept. Methods: Secondary analysis of a single-arm, open-label 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::bc59d7d96e4bffc1b121e56df59e91d2
https://hdl.handle.net/11588/913417
https://hdl.handle.net/11588/913417
Autor:
Stanley Cohen, Katie Tuckwell, Tamiko R. Katsumoto, Rui Zhao, Joshua Galanter, Chin Lee, Julie Rae, Balazs Toth, Nandhini Ramamoorthi, Jason A. Hackney, Alberto Berman, Nemanja Damjanov, Dmytro Fedkov, Slawomir Jeka, Leslie W. Chinn, Michael J. Townsend, Alyssa M. Morimoto, Mark C. Genovese, Alejandro Porto, Amelia Granel, Cecilia Asnal, Eduardo Fabian Mysler, Gladys Alicia Testa, Jose Luis Velasco Zamora, Jose Luis Cristian Moreno, Juan Pablo Gulin, Julio Hofman, Maria Rosa Ulla, Mirtha Sabelli, Pablo Alejandro Mannucci, Pablo Jorge Maid, Ana Cláudia Cauceglia Melazzi, Antônio Scafuto Scotton, Antônio Carlos Ximenes, Elisete Funes, Emerson Alves Gimenez, Flora Maria D’Andrea Marcolino, João Francisco Marques Neto, Mauro Waldemar Keiserman, Sebastião Cézar Radominski, Sônia Maria Alvarenga Anti Loduca Lima, Thaís Rohde Pavan, Valderílio Feijó Azevedo, Aneliya Koleva, Antoaneta Toncheva, Daniela Bichovska, Delina Ivanova, Dimitar Penev, Emil Dimitrov, Mariyana Mihaylova, Nadezhda Kapandjieva, Natalia Marinova, Tanya Aleksieva, Tanya Tsvetanova, Tsvetanka Petranova, Valentina Popova, Yuliy Spasov, Carlos Enrique Toro, Carlos Ernesto Arteaga Unigarro, Edwin Jauregui, Javier Dario Marquez Hernandez, Juan Jose Jaller Raad, Patricia Julieta Velez Sanchez, Chang Keun Lee, Chang‐Hee Suh, Eun Young Lee, Sang‐Heon Lee, Seong Wook Kang, Shin‐Seok Lee, Yun Jong Lee, Beatriz Elena Zazueta Montiel, Blanca Irma Pinzon de la O, Daniel Xibille Friedmann, Francisco Rosas Lopez, Isaura Rodriguez Torres, Luis Jara Quezada, Marco Maradiaga Ceceña, Miguel Cortes Hernandez, Miguel Saavedra Salinas, Agnieszka Rapa, Agnieszka Pawtel, Agnieszka Zielinska, Anna Dudek, Anna Rychlewska‐Hanczewska, Anna Strzelecka, Artur Racewicz, Barbara Stasiuk, Katarzyna Gruszecka, Krystyna Dworak, Tomasz Lowenhoff, Alexey Maslyanskiy, Andrey Rebrov, Diana Krechikova, Elena Zhugrova, Evgeniya Shmidt, Galina Matsievskaya, Irina Vinogradova, Irina Ler, Larisa Eliseeva, Ludmila Savina, Marina Stanislav, Mikhail Sandin, Natalia Zyablova, Nikolay Korshunov, Nino Mosesova, Oksana Polovnikova, Olga Nesmeyanova, Ruzana Samigullina, Sergey Moiseev, Sergey Noskov, Tatiana Raskina, Tatiana Popova, Valeriy Marchenko, Aleksandar Jovanovski, Bojana Stamenkovic, Gorica Ristic, Milijanka Lazarevic, Mirjana Veselinovic, Nada Vujasinovic‐Stupar, Predrag Ostojic, Andriy Yagensky, Andriy Gnylorybov, Dmytro Rekalov, Dmytroo Reshotko, Georgiy Dzyak, Iurii Gasanov, Ludmila Khimion, Mykola Stanislavchuk, Natalya Prykhodko, Oleg Nadashkevych, Oleg Bortkevych, Orest Abrahamovych, Roman Yatsyshyn, Samvel Turyanytsya, Svitlana Smiyan, Vadym Vizir, Victoria Kachur, Vira Tseluyko, Vladyslav Povoroznyuk, Volodymyr Koshlia, Vyacheslav Zhdan, Yurii Lymar, Yuriy Mostovoy, Angela Hawkes, Arthur Mabaquiao, Cong‐Qiu Chu, Craig Scoville, David Wyatt, Debra Weinstein, Harris McIlwain, Jacqueline Vo, Jeffrey Poiley, Joseph Forstot, Kathryn Dao, Mark Turner, Mark Genovese, Michael Borofsky, Paul Caldron, Philip Waller, Robert Levin, Samy Metyas, Scott Stein, Sharukh Shroff, Shirley Pang, Tauseef Syed, Vishala Chindalore
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Objective To evaluate fenebrutinib, an oral and highly selective noncovalent inhibitor of Bruton's tyrosine kinase (BTK), in patients with active rheumatoid arthritis (RA). Methods Patients with RA and an inadequate response to methotrexate (MTX) (co
Autor:
Jan Brzezicki, Ramon Toro-Torres, Juan Cruz Rizo Rodriguez, Eric C. Mueller, Atul Deodhar, Anna Dudek, Gunther Neeck, Roger J. Diegel, Maria Greenwald, Lianne S. Gensler, Hitoshi Goto, Judith Carrio, Seung Jae Hong, Cassandra M. Skinner, Yoshinori Taniguchi, Tatsuya Atsumi, Mikkel Østergaard, Shigeru Honjo, Clemens Scheinecker, Heinrich Resch, Rafal Plebanski, Yoshifuji Matsumoto, David H. Adams, Min Chan Park, Richard Roseff, David H. Goddard, Hiroaki Dobashi, Steven C. Kimmel, Johannes Grisar, Christine Thai, Sergio Duran Barragan, Chang Keun Lee, Tetsuya Tomita, Frederic Morin, Roel Querubin, Jose Maldonado Cocco, Craig D. Scoville, Philip J. Mease, Luminita Tronaru, Kurisu Tada, Denis Poddubnyy, Mohamed B. Sebai, Federico Ariel, Eleonora Lucero, Mark D. Harris, Kari K. Eklund, Melvin Churchill, Jeffrey L. Kaine, Cesar Ricardo Ramos Remus, Francisco Fidencio Cons Molina, Kazuhiro Hatta, Eun Bong Lee, Joachim Sieper, Alan Kivitz, Yukitaka Ueki, Jorge Velasco, Seong Wook Kang, Jürgen Braun, Sang-Heon Lee, Xiaoqi Li, Kentaro Inui, Leena Paimela, Michael E. Sayers, Arthur R. Mabaquiao, Antonio Scafuto Scotton, Sylke Wagner, Carlos Pantojas, Janina Drabiszcak-Piatkowska, Ana Maria Ramazan, Steven J. Klein, Proton Rahman, M. Hojnik, Marleen G H van de Sande, Tania L. Rivera, Amarilis Perez-De Jesus, Kathleen P. Flint, Jyothi R. Mallepalli, John E. Hull, Karel Pvelka, Evgeniya Schmidt, Mary P. Howell, Yuya Takakubo, Gaia Gallo, Walter P. Maksymowych, Joseph C. Shanahan, Marek Krogulec, Aaron Alejandro Barrera Rodriguez, Cesar Francisco Pacheco Tena, Anna Karjalainen, Pentti Jarvinen, Oscar Soto-Raices, Zdenek Dvorak, Désirée van der Heijde, Tokutaro Tsuda, Galina Matsievskaya, Sergey Yakushin, Eva Dokoupilova, Ann Leung, Luis Roimicher, Daniela Opris-Belinski, Pawel Hrycai, Tomasz Blicharshi, Kiyoshi Matsui, Hilde Carlier, Olga Ershova, Alberto Berman, Tae-Hwan Kim, Eric A. Peters, Marina Stanislav, Ana Claudia Melazzi, Martina Malcova, Louis Bessette, Sang-Hoon Lee, Helena Marzo-Ortega, Andrey Rebroy, Diego O. Viola, Rodolfo A Pardo Hidalgo
Publikováno v:
Lancet, 395(10217), 53-64
Lancet, 395(10217), 53-64. Elsevier Limited
Lancet, 395(10217), 53-64. Elsevier Limited
Summary Background Ixekizumab, a high-affinity interleukin-17A (IL-17A) monoclonal antibody, has previously shown efficacy in radiographic axial spondyloarthritis (also known as ankylosing spondylitis). We aimed to evaluate the efficacy and safety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de58e8a78134c8e494ab8c28ac8b159f
https://hdl.handle.net/1887/3181441
https://hdl.handle.net/1887/3181441
Autor:
Stanley Cohen, Chin Lee, Alberto Berman, Tamiko R. Katsumoto, Nemanja Damjanov, Mark C. Genovese, Rui Zhao, Katie Tuckwell, Dmytro Fedkov, Sławomir Jeka
Publikováno v:
Oral Presentations.
Background Fenebrutinib (GDC-0853, FEN) is a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) that is orally administered, highly selective, non-covalent, and reversible. Objectives This study evaluated the efficacy and safety of FEN comp
Autor:
Vladimir Keltsev, Mahmood Moosa Tar Mahomed Ally, Marleen Nys, Nicolino Ruperto, John F. Bohnsack, Maria Elena Rama, Hermine I. Brunner, Jordi Anton, Bernard Lauwerys, Daniel J. Lovell, R. Wong, Bindu Murthy, Diego O Viola, Ruben Cuttica, Riana van Zyl, Caroline Caillaud, Elisabeth Gervais, Gabriel Vega Cornejo, Alberto Martini, Alberto Berman, Kirsten Minden, Jade Hoang, Yash Gandhi
Publikováno v:
Saturday, 15 June 2019.
Background Efficacy of SC abatacept (ABA) in patients (pts) with polyarticular-course juvenile idiopathic arthritis (pJIA) was shown in a 2-year, open-label, Phase III international study (NCT01844518).1 Restricted growth and delayed puberty are asso
Autor:
Atul Deodhar, Lianne S. Gensler, Joachim Sieper, Michael Clark, Cesar Calderon, Yuhua Wang, Yiying Zhou, Jocelyn H. Leu, Kim Campbell, Kristen Sweet, Diane D. Harrison, Elizabeth C. Hsia, Désirée Heijde, Frederico Ariel, Cecilia Adma Asnal, Alberto Berman, Gustavo Citera, Graciela Rodriguez, Veronica Gabriela Savio, Paul Bird, Hedley Griffiths, David Nicholls, Maureen Rischmueller, Jane Zochling, Kurt De Vlam, Michel Malaise, Adrien Nzeusseu Toukap, Filip Van den Bosch, Johan Vanhoof, Rubens Bonfiglioli, Mauro Keiserman, Antonio Scafuto Scotton, Ricardo Xavier, Antonio Carlos Ximenes, Assen Atanasov, Ivan Goranov, Ivan Kazmin, Rodina Nestorova Licheva, Nikolay Nikolov, Boycho Oparanov, Rumen Stoilov, Louis Bessette, Jude Rodrigues, Ladislav Bortilik, Eva Dokoupilova, Zdenek Dvoarak, Dagmar Galatikova, Petr Nemec, Lucie Podrazilova, Gabriela Simkova, Zuzana Stejfova, Radka Moravcova, Petr Vitek, Alain Cantagrel, Athan Baillet, Beatrice Banneville, Bernard Combe, Maxime Breban, Minh Nguyen, Philippe Goupille, Juergen Braun, Andrea Everding, Joern Kekow, Ramona Koenig, Andrea Rubbert‐Roth, Torsten Witte, Attila Bartha, Edit Drescher, Kata Kerekes, Attila Kovacs, Judit Pulai, Bernadette Rojkovich, Sandor Szanto, Edit Toth, Hilario Avila, Igancio Garcia Torre, Fedra Irazoque, Marco Maradiaga, Cesar Pacheco, Marek Brzosko, Anna Dudek, Slawomir Jeka, Marek Krogulec, Brygida Kwiatkowska, Piotr Wiland, Rafal Wojciechowski, Agnieszka Zielinska, Helena Santos, Olga Bugrova, Valery Christyakov, Vladimir Gorbunov, Elena Ilivanova, Elena Zemerova, Rima Kamalova, Tatyana Kameneva, Galina Macievskaya, Irina Marusenko, Alexey Maslyansky, Svetlana Myasoedova, Leisan Myasoutova, Boris Nemtsov, Olga Nesmeyanova, Tatyana Plaksina, Tatyana Pokrovskaya, Svetlana Polyakova, Andrey Rebrov, Liudmila Savina, Svetlana Smakotina, Marina Stanislav, Olga Ukhanova, Irina Vinogradova, Elena Zonova, Han Joo Baek, Tae‐Hwan Kim, ChangKeun Lee, SangHeon Lee, Sang‐Hoon Lee, Shin‐Seok Lee, Sung‐Hwan Park, YeongWook Song, Chang‐Hee Suh, Juan Amarelo Ramos, Franciso Javier Blanco, Eduardo Collantes, Miguel Consuelo Diaz, Maria Luz Garcia Vivar, Jordi Gratacos, Xavier Juanola, Der‐Yuan Chen, Hsiang‐Cheng Chen, Kun‐Hung Chen, Ying‐Chou Chen, Ying‐Ming Chiu, Shue‐Fen Luo, Shih‐Tzu Tsai, Jui‐Cheng Tseng, Cheng‐Chung Wei, Meng‐Yu Weng, Orest Abrahamovych, Dmytro Reshotko, Oleksandr Golovchenko, Ihor Hospodarsky, Oleg Iaremenko, Olena Levchenko, Oleksandr Dudnyk, Olena Garmish, Olena Grishyna, Galyna Protsenko, Dmytro Rekalov, Svitlana Smiyan, Mykola Stanislavchuk, Svitlana Trypilka, Vira Tseluyko, Samvel Turianytsia, Viktoriya Vasylets, Nataliya Virstyuk, Yaroslav Kleban, Coziana Ciurtin, Karl Gaffney, Wiranthi Gunasekera, Kirsten Mackay, Jon Packham, Raj Sengupta, Hasan Tahir, Jacob Aelion, Ralph Bennett, Julio Gonzalez‐Paoli, Robert M. Griffin, Michael Grisanti, Jyothi Mallepalli, Eric Peters, Joy Schechtman, Atul Singhal
Publikováno v:
Arthritis and Rheumatology, 71(2), 258-270. WILEY
Deodhar, A; Gensler, LS; Sieper, J; Clark, M; Calderon, C; Wang, Y; et al.(2018). Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.. Arthritis & rheumatology (Hoboken, N.J.). doi: 10.1002/art.40728. UCSF: Retrieved from: http://www.escholarship.org/uc/item/3x5990zb
Arthritis & rheumatology (Hoboken, N.J.), vol 71, iss 2
Deodhar, A; Gensler, LS; Sieper, J; Clark, M; Calderon, C; Wang, Y; et al.(2018). Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.. Arthritis & rheumatology (Hoboken, N.J.). doi: 10.1002/art.40728. UCSF: Retrieved from: http://www.escholarship.org/uc/item/3x5990zb
Arthritis & rheumatology (Hoboken, N.J.), vol 71, iss 2
Author(s): Deodhar, Atul; Gensler, Lianne S; Sieper, Joachim; Clark, Michael; Calderon, Cesar; Wang, Yuhua; Zhou, Yiying; Leu, Jocelyn H; Campbell, Kim; Sweet, Kristen; Harrison, Diane D; Hsia, Elizabeth C; van der Heijde, Desiree | Abstract: Objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f232b4efcd4d46d6ba1ded5ac5cc76d0
https://doi.org/10.1002/art.40728
https://doi.org/10.1002/art.40728
Autor:
Christian A. Waimann, E. Velozo, F Colombres, Pellet C, Federico Ceccato, L. Carlevaris, Juan Pablo Pirola, Salinas Hmj, Josefina Marcos, G. Salvatierra, María Victoria Martire, Gustavo Citera, Munoz Ma, Anastasia Secco, Del Para F, M. Crespo, Quintana R, M. O. Leal, M. Sacnun, M A García, Abdala M, Landi M, Ana Quinteros, Alberto Berman, G. Bennasar, M. Manzano, A. C. Costi, Francisco Caeiro, H Berman, Enrique R. Soriano, N. Benzaquén, Amaya Cg, Sergio Paira, Javier Rosa, Ledesma C, Emmanuel Bertiller, Juarez, Rillo
Publikováno v:
Rheumatology: Current Research.
Methods: We included a cohort of patients with diagnosis of early RA of less than 2 years of disease duration who not respond to MTX monotherapy, according to medical judgment, and added step-up combination with LEF. Data were collected every 3 month
Autor:
Alberto Berman, Philip J. Mease, Jun Xing, R. Wong, Edit Drescher, Subhashis Banerjee, Alice B. Gottlieb
Publikováno v:
Arthritis & Rheumatology. 68:2163-2173
Objective To evaluate the efficacy of clazakizumab, a monoclonal antibody with high affinity and specificity for the interleukin-6 (IL-6) cytokine, in psoriatic arthritis (PsA). Methods In this randomized, double-blind, placebo-controlled, dose-rangi